Stock Market News

Epic Research Update : Cipla

Epic Update Cipla
Epic Update Cipla

Cipla, India’s second-largest drug maker by market share has formed an India-specific strategic partnership with MSD, one of the world’s leading players in HIV innovative treatment. Within the scope of the partnership, Cipla will have a non-exclusive license to market, promote and distribute MSD’s raltegravir 400mg tablet, under a different brand name in India.

For more information ✆ – 0731-6642300 or Visit https://www.epicresearch.co/

Share Button
Epic Research
Epic Research
Epic Research - Investment Adviser is a leading financial services provider with presence in Indian and other global capital markets. Call on - 0731-664-2300
https://www.epicresearch.co/